Skip to content

Omnicell OMCL Treasury Stock

Treasury Stock at other companies

Baxter International logo
Baxter InternationalBAX
$10.74B-1.8%
Cencora logo
CencoraCOR
$10.44B+1.0%
ICU Medical logo
ICU MedicalICUI
$25.18M+41,872%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$325M+1,200%
CVS Health logo
CVS HealthCVS
$36.71B-0.1%
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.8B-7.2%
Enterprise value$1.54B-0.4%
P/E116.4×
P/S1.5×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The official record: Omnicell’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's treasury stock?
Omnicell (OMCL) reported treasury stock of $368.31M in Q1 2026.
How has Omnicell's treasury stock changed year-over-year?
Omnicell's treasury stock increased by 26.9% year-over-year, from $290.32M to $368.31M.
What is the long-term trend for Omnicell's treasury stock?
Over 5 years (2020 to 2025), Omnicell's treasury stock has grown at a 9.1% compound annual growth rate (CAGR), from $238.11M to $368.31M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.